Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Preliminary findings suggest that this higher dosage may boost the drug's ability to control blood sugar, potentially offering more significant outcomes for individuals with type 2 diabetes. Further study is underway to fully evaluate th